femtech focus

Exclusive: Houston entrepreneur launches femtech nonprofit and accelerator partnership

Brittany Barreto launched FemTech Focus to help call attention to women's health and wellness, as well as to help accelerate companies with tech solutions within the field. Photo courtesy of FemTech Focus

It's about time women's health and wellness took center stage, in Brittany Barreto's opinion, so she's launched a nonprofit to make that happen.

Houston entrepreneur Barreto recently left her position at Capital Factory to focus on FemTech Focus, an organization dedicated to increasing attention on femtech and providing resources and support for founders in the space. The nonprofit launched its podcast in April and has garnered over 5,000 subscribers across 40 countries.

"What we're focusing on for 2020 is awareness," Barreto says, adding that the podcast is key to that mission.

Barreto says next year, however, it's the her plan to create a 12-week virtual accelerator program and venture fund. The first iteration of the program is going to focus on health care — digital health, medical device, and therapeutics — for companies between seed to series A stage.

"Femtech startups actually need a little bit of different advice — that's why I'm very bullish on creating a femtech accelerator," Barreto says. "In femtech, we have some unique barriers. If you just go to a general accelerator, they might not cover these issues, and you'll be blindsighted."

Barreto says, based on the interviews she's done for the podcast, that some of these unique challenges include working with the Food and Drug Administration, creating referral programs that are extremely successful among women, and approaching "taboo" topics, which a lot of femtech companies have to deal with.

While Barreto continues working her plans for the program, she says she came across an opportunity to work with The Guild, a a woman's professional networking platform that has its own accelerator, to create a femtech-focused virtual program this fall. This partnership, Barreto says, will allow her to get her feet wet in the virtual acceleration field while also getting to help femtech entrepreneurs sooner.

Applications for Guild Academy - Femtech Edition, powered by Femtech Focus, are open online and will close September 18. The 8-week program will then wrap up mid November ahead of Thanksgiving. The program is not limited to female founders, and the cohort is looking for around 25 companies.

If you're interested, apply online and check out Barreto's Ask Me Anything event today, Thursday, September 10 at 1 pm.

Trending News

Building Houston

 
 

You can now hop online and invest in this promising cell therapy startup. Photo via Getty Images

A clinical-stage company headquartered in Houston has opened an online funding campaign.

FibroBiologics, which is developing fibroblast cell-based therapeutics for chronic diseases, launched a campaign with equity crowdfunding platform StartEngine. The platform lets anyone — regardless of their net worth or income level — to invest in securities issued by startups.

The funding, according to a press release, will be used to support ongoing operations of Fibrobiologics and advance its clinical programs in multiple sclerosis, degenerative disc disease, wound care, extension of life, and cancer.

"We're excited to partner with StartEngine on this campaign. StartEngine has over 600,000 investors as part of their community and has raised over half a billion dollars for its clients," says FibroBiologics' Founder and CEO Pete O'Heeron, in the release.

"This is an exciting time at FibroBiologics as we continue progressing our clinical pipeline and developing innovative therapies to treat chronic diseases," he continues. "This new funding will fuel our growth in the lab and bring us one step closer to commercialization."

The campaign, launched this week, already has over 100 investors, at the time of publication, and has raised nearly $2 million, according to the page. The minimum investment is set at around $500, and the company's indicated valuation is $252.57 million.

In 2021, FibroBiologics announced its intention of going public. Last year, O'Heeron told InnovationMap on the Houston Innovators Podcast of the company's growth plans as well as the specifics of the technology.

Only two types of cells — stem cells and fibroblasts — can be used in cell therapy for a regenerative treatment, which is when specialists take healthy cells from a patient and inject them into a part of the body that needs it the most. As O'Heeron explains in the podcast, fibroblasts can do it more effectively and cheaper than stem cells.

"(Fibroblasts) can essentially do everything a stem cell can do, only they can do it better," says O'Heeron. "We've done tests in the lab and we've seen them outperform stem cells by a low of 50 percent to a high of about 220 percent on different disease paths."


Trending News